p53 Mutation and Loss of Heterozygosity on Chromosomes 17 and 10 during Human Astrocytoma Progression

Cancer Research

Volumn 52, Issue 3, 1992, Pages 674-679

  Fults, Dan ^a,b   Brockmeyer, Douglas ^a   Tullous, Micam W ^a   Pedone, Carolyn A ^a  

^a Division of Neurosurgery   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; ASTROCYTOMA; BRAIN CANCER; CANCER STAGING; CHROMOSOME; GLIOBLASTOMA; HUMAN; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

AMINO ACID SEQUENCE; ASTROCYTOMA; BASE SEQUENCE; BRAIN NEOPLASMS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 10; CHROMOSOMES, HUMAN, PAIR 17; CLONING, MOLECULAR; CODON; DNA, NEOPLASM; EXONS; GENES, P53; GENETIC MARKERS; GLIOBLASTOMA; HUMAN; MOLECULAR SEQUENCE DATA; MUTATION; OLIGODEOXYRIBONUCLEOTIDES; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026547577     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Mueller, W., Afra, D., and Schroeder, R. Supratentorial recurrences of gliomas. Morphological studies in relation to time intervals with astrocyto mas. Acta Neurochir. (Wien), 37: 75-91, 1977.
2. Burger, P. C., Vogel, F. S., Green, S. B., and Strike, T. A. Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications. Cancer (Phila.), 56: 1106-1111. 1985.
3. James. C. D., Carlbom, E., Dumanski, J. P., Hansen, M., Nordenskjold, M., Collins, V. P., and Cavenee, W. K. Clonal genomic alterations in glioma malignancy stages. Cancer Res., 48: 5546-5551, 1988.
4. Fujimoto, M., Fulls, D. W., Thomas, G. A., Nakamura, Y., Heilbrun, P., White, R., Story, J. L., Naylor, S. L., Kagan-Hallet, K. S., and Sheridan, P. J. Loss of heterozygosity on chromosome 10 in human glioblastoma multiforme. Genomics, 4: 210-214, 1989.
5. Fults, D., Pedone, C. A., Thomas, G. A., and White, R. Allelotype of human malignant astrocytoma. Cancer Res., 50: 5784-5789, 1990.
6. James, C. D., Carlbom, E., Nordenskjold, M., Collins, V. P., and Cavenee, W. K. Mitotic recombination of chromosome 17 in astrocytomas. Proc. Natl. Acad. Sci. USA, 86: 2858-2862, 1989.
7. EI-Azouzi, M., Chung, R. Y., Farmer, G. E., Martuza, R. L., Black, P. McL., Rouleau, G. A., Hettlich, C., Hedley-Whyte, E. T., Zervas, N. T., Panagopoulos, K., Nakamura, Y., Gusella, J. F., and Seizinger, B. R. Loss of distinct regions on the short arm of chromosome 17 associated with tumorigenesis of human astrocytomas. Proc. Natl. Acad. Sci. USA, 86: 7186-7190, 1989.
8. Fults, D., Tippets, R. H., Thomas, G. A., Nakamura, Y., and White, R. Loss of heterozygosity for loci on chromosome 17p in human malignant astrocy toma. Cancer Res., 49: 6572-6577, 1989.
9. Baker, S. J., Fearon, E. R., Nigro, J. M., Hamilton, S. R., Preisinger, A. C., Jessup, J. M., vanTuinen, P., Ledbetter, D. H., Barker, D. F., Nakamura, Y., White, R., and Vogelstein, B. Chromosome 17 deletions and p53 gene mutations in colorela!carcinomas. Science (Washington DC), 244: 217-221, 1989.
10. Takahashi, T., 'au, M. M., Chiba, L., Birrer, M. J., Rosenberg, R. K., Vinocour, M., Levitt, M., Pass, H., Gazdar, A. F., and Minna, J. D. P53: a frequent target for genetic abnormalities in lung cancer. Science (Washington DC), 246: 491-494, 1989.
11. Nigro, J. M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hosteller, R., Cleary, K., Bigner, S. H., Davidson, N., Baylin, S., Devilee, P., Glover, T., Collins, F. S., Weston, A., Modali, R., Harris, C. C., and Vogelstein, B. Mutations in the p53 gene occur in diverse human tumour types. Nature (Lond.), 342: 705-708, 1989.
12. Mulligan, L. M., Matlashewski, G. J., Scrable, H. J., and Cavenee, W. K. Mechanisms of p53 loss in human sarcomas. Proc. Natl. Acad. Sci. USA, 7:5863-5867, 1990.
13. Human Gene Mapping 10(1989): Tenth International Workshop on Human Gene Mapping. Cytogenet. Cell Genet., 5: 1-1148, 1989.
14. Lamb, P., and Crawford, L. Characterization of the human p53 gene. Mol. Cell. Biol., 6: 1379-1385, 1986.
15. Buchman, V. L., Chumakov, P. M., Ninkina, N. N., Samarina, O. P., and Georgiev, G. P., A variation in the structure of the protein-coding region of the human p53 gene. Gene, 70: 245-252, 1988.
16. Orila, M., Suzuki, Y., Sekiya, T., and Hayashi, K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics, 5: 874-879, 1989.
17. Hata, A., Robertson, M., Emi, M., and Lalouel, J-M. Direct detection and automated sequencing of individual alelesafter electrophoretic strand sepa ration: identification of a common nonsense mutation in exon 9 of the human lipoprotein lipase gene. Nucleic Acids Res., 18: 5407-5411, 1990.
18. Sanger, F., Nicklen, S., and Coulson, A. R. DNA sequencing with chainterminating inhibitors. Proc. Natl. Acad. Sci. USA, 74: 5463-5467, 1977.
19. Eliyahu, D., Goldfinger, N., Pinhasi-Kimhi, O., Shaulsky, G., Skurnik, Y., Arai, N., Rotter, V., and Oren, M. Meth A fibrosarcoma cells express two transforming mutant p53 species. Oncogene, 3: 313-321, 1988.
20. Levine, A. J., Momand, J., and Finlay, C. A. The p53 tumour suppressor gene. Nature (Lond.), 351: 453-456, 1991.
21. Fearon, E. R., and Vogelstein, B. A genetic model for colorectal tumorigen esis. Cell, 61: 759-767, 1990.
22. Bigner, S. H., Mark, J., and Bigner, D. D. Cytogenetics of human brain tumors. Cancer Genet. Cytogenet., 47: 141-154, 1990.